While the RNI for maintenance is only 1.5 g daily, therapeutic oral doses typically range from: 50-150 g daily for mild deficiency prevention in at-risk groups 1,000-2,000 g daily for treating confirmed deficiency without malabsorption Some formulations contain up to 5,000 g, though there is no proven additional benefit over 1,000-2,000 g for most patients The reason for this dosage discrepancy lies in absorption efficiency
Without ongoing B12 replacement, deficiency and symptoms will typically recur within months to years of discontinuation
Vitamin E increases production of vasodilator prostanoids in human aortic endothelial cells through opposing effects on cyclooxygenase-2 and phospholipase A2
References: Pentadecapeptide BPC 157 Enhances the Growth Hormone Receptor Expression in Tendon Fibroblasts The effect of pentadecapeptide BPC 157 on hippocampal ischemia/reperfusion injuries in rats Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts
Always recalculate your dosing when changing vial sizes, even if you use the same water volume